Juan Sanz-Villafruela; Cristina Bermejo-Casadesus; Elisenda Zafon; Marta Martínez-Alonso; Gema Durá; Aranzazu Heras; Iván Soriano-Díaz; Angelo Giussani; Enrique Ortí; Francesc Tebar; Gustavo Espino; Anna Massaguer "Insights into the anticancer photodynamic activity of Ir(III) and Ru(II) polypyridyl complexes bearing β-carboline ligands." European Journal of Medicinal Chemistry 276 (2024): -. Sanz-Villafruela, J.; Bermejo-Casadesús, C.; Riesco-Llach, G.; Iglesias, M.; Martínez-Alonso, M.; Planas, M.; Feliu, L.; Espino, G.; Massaguer, A. "Bombesin-targeted delivery of β‑carboline-based Ir(III) and Ru(II) photosensitizers for a selective photodynamic therapy of prostate cancer." Inorganic Chemistry 63 (2024): 19140-19155. Juan Sanz-Villafruela; Cristina Bermejo-Casadesús; Marta Martínez-Alonso; Artur Moro; João C Lima; Anna Massaguer; Gustavo Espino "Towards efficient Ir(III) anticancer photodynamic therapy agents by extending π-conjugation on N^N ligands." Dalton Transactions (2024): -. José Manuel Veiga Del Pino; Franco Scalambra; Cristina Bermejo-Casadesús; Anna Massaguer; Federico García-Maroto; Antonio Romerosa "Study of the biological activity of photoactive bipyridyl-Ru(II) complexes containing 1,3,5-triaza-7-phosphaadamantane (PTA)." Journal of Inorganic Biochemistry 246 (2023): -. Alba Tristán-Noguero; Irene Fernández-Carasa; Carles Calatayud; Cristina Bermejo-Casadesús, Meritxell Pons-Espinal; Arianna Colini Baldeschi; Leticia Campa; Francesc Artigas; Analia Bortolozzi; Rosario Domingo-Jiménez; Salvad "iPSC-based modeling of THD recapitulates disease phenotypes and reveals neuronal malformation." Embo Molecular Medicine (2023): -.